Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2020
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2020
- December 20204 results available
- November 20202 results available
- October 20209 results available
- September 20208 results available
- August 20201 results available
- July 20207 results available
- June 20205 results available
- May 20209 results available
- April 20208 results available
- March 20207 results available
- February 20202 results available
- January 20203 results available
Displaying 16 - 30 of 65 items.
FIBRISTAL (ulipristal acetate tablets, 5 mg) - Voluntary Withdrawal in Canada due to Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-30
Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market
AlertPublic advisory | 2020-09-30
All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concerns
AlertPublic advisory | 2020-09-24
Unauthorized health products sold on Steroid Hub Canada website may pose serious health risks
AlertPublic advisory | 2020-09-18
Unauthorized products may pose serious health risks (September 16, 2020: Part 1)
AlertPublic advisory | 2020-09-16
Unauthorized products may pose serious health risks (September 16, 2020: Part 2)
AlertPublic advisory | 2020-09-16
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
AlertHealth professional risk communication | 2020-09-15
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-14
Prescription Cough and Cold Products Containing Opioids and the Risk of Opioid Use Disorder in Children and Adolescents (< 18 years of age)
AlertHealth professional risk communication | 2020-08-24
Non-prescription pain relief products containing codeine are not recommended for use in people under 18 years of age
AlertPublic advisory | 2020-07-31
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
AlertPublic advisory | 2020-07-28
Status of ranitidine drugs in Canada
AlertPublic advisory | 2020-07-23
Methadone Treatment of Opioid Dependence and Potential Risk of Lack of Effect when Switching between Different Products
AlertHealth professional risk communication | 2020-07-17
Three lots of antidiuretic DDAVP Spray recalled because of potential overdose risk
AlertPublic advisory | 2020-07-16
Certain vials of fertility drug Cetrotide recalled because of potential contamination
AlertPublic advisory | 2020-07-04